ARTELO BIOSCIENCES, INC. Increase Decrease In Operating Lease Liability
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase Decrease In Operating Lease Liability of -$19.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$9.00K.
- ARTELO BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$10.00K.
- ARTELO BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$9.00K.
- ARTELO BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$9.00K.
- ARTELO BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2022 was -$43.00K.
- ARTELO BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2021 was -$2.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 4 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$19.00K 10-Q · filed 2026-08-12 | -$28.00K derived: sum of 3 quarters · filed 2026-08-12 | -$37.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-14 | -$19.00K derived: sum of 2 quarters · filed 2026-05-14 | -$28.00K derived: sum of 3 quarters · filed 2026-05-14 | -$37.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$9.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$18.00K derived: sum of 2 quarters · filed 2026-03-17 | -$27.00K derived: sum of 3 quarters · filed 2026-08-12 | -$35.00K 8-K · filed 2026-03-17 | |
| 2025-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$18.00K derived: sum of 2 quarters · filed 2026-08-12 | -$26.00K 10-Q · filed 2025-11-12 | -$34.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$17.00K 10-Q · filed 2026-08-12 | -$25.00K derived: sum of 3 quarters · filed 2026-08-12 | -$33.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$8.00K 10-Q · filed 2026-05-14 | -$16.00K derived: sum of 2 quarters · filed 2026-05-14 | -$24.00K derived: sum of 3 quarters · filed 2026-05-14 | -$30.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$8.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$16.00K derived: sum of 2 quarters · filed 2026-03-17 | -$22.00K derived: sum of 3 quarters · filed 2026-03-17 | -$30.00K 8-K · filed 2026-03-17 | |
| 2024-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$14.00K derived: sum of 2 quarters · filed 2025-11-12 | -$22.00K 10-Q · filed 2025-11-12 | -$30.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$6.00K derived: 10-Q 6 month − 8-K 3 month · filed 2025-08-13 | -$14.00K 10-Q · filed 2025-08-13 | -$22.00K derived: sum of 3 quarters · filed 2025-08-13 | -$31.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$8.00K 8-K · filed 2025-07-11 | -$16.00K derived: sum of 2 quarters · filed 2025-07-11 | -$25.00K derived: sum of 3 quarters · filed 2025-07-11 | -$37.00K derived: sum of 4 quarters · filed 2025-07-11 | |
| 2023-12-31 | -$8.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | -$17.00K derived: sum of 2 quarters · filed 2025-07-11 | -$29.00K derived: sum of 3 quarters · filed 2025-07-11 | -$40.00K 8-K · filed 2025-07-11 | |
| 2023-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$21.00K derived: sum of 2 quarters · filed 2024-11-12 | -$32.00K 10-Q · filed 2024-11-12 | -$43.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$23.00K 10-Q · filed 2024-08-13 | -$34.00K derived: sum of 3 quarters · filed 2024-08-13 | -$44.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$11.00K 10-Q · filed 2024-05-13 | -$22.00K derived: sum of 2 quarters · filed 2024-05-13 | -$32.00K derived: sum of 3 quarters · filed 2024-05-13 | -$46.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$21.00K derived: sum of 2 quarters · filed 2024-03-25 | -$35.00K derived: sum of 3 quarters · filed 2024-03-25 | -$43.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$24.00K derived: sum of 2 quarters · filed 2023-11-13 | -$32.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$22.00K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$8.00K 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | -$7.00K 10-K · filed 2023-03-31 | ||||
| 2021-08-31 | -$2.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |